A. DEFINITION The objective of the In Vivo Studies Core is to provide a venue for focusing the human resources, facilities, new technology and equipment necessary for In vivo study of humans and animals. The Core serves to fully integrate investigations at the molecular, cellular and organ system level that are currently performed within the other Cores of the Center. The Core is organized to bring together expertise and in vivo techniques from different disciplines to investigate the role of peptide hormones in a wide variety of gastrointestinal functions. Toward these goals, the major services provided by the In Vivo Studies Core are as follows: 1. To provide a variety of acute and chronic animal models for in vivo evaluation of the biological actions of peptide hormones. 2. To examine the physiological changes in mouse models following transgene expression or gene mutation. 3. To provide in vivo techniques and tests for the Investigation of the physiology and pathophysiology of gastrointestinal peptides in humans. 4. To facilitate innovations in methodology and to develop sophisticated new techniques for In vivo studies. 5. To educate and consult on human clinical studies as well as the application of In vivo techniques so that basic physiological and biochemical questions pertaining to peptide hormones may be answered.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034933-29
Application #
8588315
Study Section
Special Emphasis Panel (ZDK1-GRB-8)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
29
Fiscal Year
2014
Total Cost
$136,233
Indirect Cost
$48,152
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Meral, Rasimcan; Ryan, Benjamin J; Malandrino, Noemi et al. (2018) ""Fat Shadows"" From DXA for the Qualitative Assessment of Lipodystrophy: When a Picture Is Worth a Thousand Numbers. Diabetes Care 41:2255-2258
Menon, Rajasree; Otto, Edgar A; Kokoruda, Austin et al. (2018) Single-cell analysis of progenitor cell dynamics and lineage specification in the human fetal kidney. Development 145:
Xiong, Yi; Torsoni, Adriana Souza; Wu, Feihua et al. (2018) Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases. Elife 7:
Liu, Yan; Jiang, Lin; Sun, Chengxin et al. (2018) Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis. Nat Commun 9:2751
Dame, Michael K; Attili, Durga; McClintock, Shannon D et al. (2018) Identification, isolation and characterization of human LGR5-positive colon adenoma cells. Development 145:
Brady, Graham F; Kwan, Raymond; Ulintz, Peter J et al. (2018) Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease. Hepatology 67:1710-1725
Wang, Zhen; Ocadiz-Ruiz, Ramon; Sundaresan, Sinju et al. (2018) Isolation of Enteric Glial Cells from the Submucosa and Lamina Propria of the Adult Mouse. J Vis Exp :
Kim, D-I; Liao, J; Emont, M P et al. (2018) An OLTAM system for analysis of brown/beige fat thermogenic activity. Int J Obes (Lond) 42:939-945
Park, Min-Jung; Iyer, Sapna; Xue, Xiang et al. (2018) HIF1-alpha Regulates Acinar Cell Function and Response to Injury in Mouse Pancreas. Gastroenterology 154:1630-1634.e3
Cho, Chun-Seok; Park, Hwan-Woo; Ho, Allison et al. (2018) Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1-mediated p62/sequestosome 1 phosphorylation. Hepatology 68:1331-1346

Showing the most recent 10 out of 757 publications